Arcus Biosciences - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $85,758.30 -3.30%
Ethereum $2,925.27 -5.33%
BNB $846.31 -4.25%
Optimism $0.28 -5.85%
Arbitrum $0.19 -5.85%
Solana $124.11 -4.74%
Polygon $0.22 +2.77%
Cosmos $2.02 -4.60%
Avalanche $12.30 -5.35%

Bitcoin $85,758.30 -3.30%
Ethereum $2,925.27 -5.33%
BNB $846.31 -4.25%
Optimism $0.28 -5.85%
Arbitrum $0.19 -5.85%
Solana $124.11 -4.74%
Polygon $0.22 +2.77%
Cosmos $2.02 -4.60%
Avalanche $12.30 -5.35%

Arcus Biosciences

company

Investors

Number of Lead Investors

Number of Investors

3

18

Arcus Biosciences is funded by 18 investors. Gilead Sciences and GV are the most recent investors.

Investor Name	Lead Investor	Funding Round
Gilead Sciences	Yes	Post-IPO Equity
GV	Yes	Series C
Aisling Capital	-	Series C
Biotechnology Value Fund	-	Series C
Celgene	-	Series C
Decheng Capital	-	Series C
Droia Ventures	-	Series C
EcoR1 Capital	-	Series C
Foresite Capital	-	Series C
Hillhouse Capital Group	-	Series C
Invus	-	Series C
Leerink Partners	-	Series C
Taiho Ventures	-	Series C
The Column Group	-	Series C
Wellington Management	-	Series C
Novartis	-	Series B
RTA Capital	-	Series B
Stanford University	-	Series B